← All analysis
ImpliedLens › BMY
BMY

Bristol-Myers Squibb Co Stock Analysis

NEW YORK STOCK EXCHANGE, INC. · Pharmaceuticals
$54.00
▼ -2.32%
Latest quote · typically 15 min delayed
$55.20
Open
$55.33
High
$53.44
Low
$55.28
Prev close
$110.27B
Market cap
Analyze BMY in depth →
Guests get 2 analyses/day. Create a free account for 5/day.

What you get with ImpliedLens

📊
Financial statements
Income, balance sheet, cash flow from SEC filings with 30+ calculated ratios.
🧮
DCF valuation
Customizable discounted cash flow model with live inputs.
🎯
Analyst targets
Price targets, recommendation breakdowns, earnings surprises.
🏦
Institutional context
Ownership data and aggregated FINRA OTC activity.
📋
SEC filings
Direct links to 10-K, 10-Q, 8-K, and proxy statements.
📈
Projection models
Bull/base/bear scenario modeling with editable assumptions.

Questions to answer before investing in BMY

01Which products and pipeline milestones drive Bristol-Myers Squibb Co's next five years of cash flow?
02Which risks would invalidate the investment thesis for BMY?
03How does BMY's valuation compare with its growth, quality, and closest alternatives?

Analyze another ticker

GILDISRGABTDHRLOWTGTSBUXCMGDELMT